Solco Biomedical Co., Ltd. (CEO. Seo Gon Kim, www.solco.co.kr), a high technology medical company made sales agency agreement and implant supply agreement with the total value of $1.25M  to a Thai medical company, Star Instrument(Neoplasm).

Followed by the agreement, Solco finally gets to have the exclusive sales agent right to Star Instrument(Neopharm) in Thai  including of the following 3 items; 4CIS Solar Spine System, 4CIS One-Touch Cage System, 4CIS Modular Intervertibral Cage System amongst Solco¡¯s orthopedic/neurosurgical implants, and will supply for the next 5 years at least the export value of $1.25M.

In this, Star Instrument (Neopharm)¡¯s company CEO and four executives visited Solco   where the company headquarter in Pyoungtaek for this agreement, and discussed about further sales marketing solution in various dimension. 

The company official of international sales department says, ¡°We will continuously expand our sales markets, not just in Thai as well as other south eastern Asian countries such as Malaysia, Singapore and so on.¡±